share_log

賽生藥業：交易所通告 - 復牌

SCICLONE PHARMA: EXCHANGE NOTICE - RESUMPTION OF TRADING

香港交易所 ·  Apr 2 08:32
Summary by Futu AI
賽生藥業控股有限公司（證券代號：06600）宣布，公司股份將於2024年4月2日上午九時正恢復在香港交易所的買賣。此次復牌意味著賽生藥業的股票交易將重新開放，投資者可再次進行交易。
賽生藥業控股有限公司（證券代號：06600）宣布，公司股份將於2024年4月2日上午九時正恢復在香港交易所的買賣。此次復牌意味著賽生藥業的股票交易將重新開放，投資者可再次進行交易。
SESONG PHARMACEUTICAL HOLDINGS LIMITED (STOCK CODE: 06600) ANNOUNCED THAT THE COMPANY'S SHARES WILL RESUME TRADING ON THE HONG KONG EXCHANGE AT 9:00 A.M. ON APRIL 2, 2024. This reissue means that stock trading in Sai Son Pharmaceuticals will be reopened, allowing investors to trade again.
SESONG PHARMACEUTICAL HOLDINGS LIMITED (STOCK CODE: 06600) ANNOUNCED THAT THE COMPANY'S SHARES WILL RESUME TRADING ON THE HONG KONG EXCHANGE AT 9:00 A.M. ON APRIL 2, 2024. This reissue means that stock trading in Sai Son Pharmaceuticals will be reopened, allowing investors to trade again.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

The translation is provided by third-party software.


The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.